The study found that Medicare Part D’s share of annual spending on ultra-expensive drugs increased by 1,170 percent between 2012 and 2018, largely because more beneficiaries were prescribed such drugs during this time period.
The researchers said their findings underscore a national conversation about ultra-expensive drug’s sustainability and affordability.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
